Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of obesity and overweight
3.2.1.2 Growing approval for obesity treatment drugs
3.2.1.3 Increasing awareness towards fitness activities
3.2.1.4 Growing demand for bariatric surgery to treat extreme obesity
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increasing incidence of adverse events
3.2.2.2 Lack of standardization in nutraceuticals
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product & Services, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Supplements
5.3 Drugs
5.3.1 GLP-1 receptor agonists
5.3.2 Lipase inhibitors
5.3.3 Combination drugs
5.3.4 Serotonin receptor agonists
5.3.5 Other drugs
5.4 Equipment
5.4.1 Fitness equipment
5.4.2 Fitness monitoring equipment
5.4.3 Surgical equipment
5.4.4 Other equipment
5.5 Services
Chapter 6 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Adult
6.3 Children
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Allurion
8.2 Amgen Inc.
8.3 Boehringer Ingelheim International GmbH
8.4 Eisai Co., Ltd.
8.5 Equinox Inc.
8.6 FOUND
8.7 Herbalife International of America, Inc.
8.8 Johnson & Johnson Services Inc. (Ethicon Inc.)
8.9 Kellogg Co.
8.10 Lifetime Fitness Inc.
8.11 Medtronic plc
8.12 Novo Nordisk A/S
8.13 Nutrisystem, Inc.
8.14 OptiBiotix Online
8.15 PRISTYN CARE
8.16 Roman Health Ventures Inc.
8.17 Takeda Pharmaceutical Company Ltd.
8.18 Teleflex Inc.
8.19 VIVUS LLC.
8.20 WW International, Inc.
